Background Image

AN ESTABLISHED & GROWING PORTFOLIO

Solutions that support patient needs

LEARN MORE

Therapy Area

  • Analgesia
    TradeGeneric Name
    OxyContin®, OxyNEO®, OxyContin OTR®Oxycodone (prolonged release)
    OxyNorm®Oxycodone (immediate release)
    MST Continus®, MS Contin®Morphine
    Tramal® , Tramundin®, Tramcontin®, Zytram®Tramadol Hydrochloride
    Targin®Oxycodone / Naloxone
    Norspan®, Sovenor® BuTrans®, Restiva®Buprenorphine
    Lignopad®Lidocaine
    Transtec®Buprenorphine
  • Oncology
    TradeGeneric Name
    Depocyte™Cytarabine Liposome Injection
    Folotyn®Pralatrexate
    Aloxi®Palonosetron (injection/oral)
    Zevalin®Ibritumomab Tiuxetan (Intravenous route)
     Akynzeo®Netupitant / Palonosetron
    Mundesine™Forodesine
  • Ophthalmology
    TradeGeneric Name
    TIMOPTIC®, TIMOPTIC XE® and TIMOPTIC® Preservative FreeTimolol Maleate
    SAFLUTAN®Tafluprost
    TRUSOPT® and TRUSOPT® Preservative FreeDorzolamide Hydrochloride Ophthalmic Solution
    COSOPT® and COSOPT® Preservative FreeDorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution
  • Respiratory
    TradeGeneric Name
    Flutiform®Fluticasone propionate / Formoterol fumarate
    Uniphyl®Theophylline
  • Specialty Care
    TradeGeneric Name
    Lodotra®Modified-release Prednisone
    Intermezzo™Zolpidem Tartrate
    Biphentin®Methylphenidate hydrochloride
    Targin RLS®Oxycodone / Naloxone
  • Consumer Healthcare
    TradeGeneric Name
    BETADINE®Povidone-iodine
    BETAPLAST®/Medifoam® B, N, F, S and HPolyurethane hydrophilic foam dressing (B,N,F and S)
    Hydrocolloid dressing (H)
    Senokot®Sennosides
    BETADINE® Repigel/Repithel®Liposomal hydrogel with 3% povidone-iodine (PVP-ILH, Repithel)

Please refer to individual countries for full product indication, and local prescribing information.

Mundipharma actively works to ensure that its medicines are marketed responsibly and in accordance with the regulatory frameworks in each country it operates in. Mundipharma prides itself on being an ethical company, and continues to work closely with regulators, and within strict regulatory constraints, to address the unmet need of patients across the emerging world.

Regulatory requirements in various countries limit the product information that Mundipharma Pte Ltd can provide. Please refer to your local representative office and the locally approved prescribing information for more details on the product and indications.  Furthermore, Mundipharma Pte Ltd provides the information for readers from many countries in the Asia Pacific, Middle East, Africa and Latin America region. Mundipharma Pte Ltd is providing the information as of this date and does not undertake any obligation to update any forward-looking statements contained in this website as a result of new information, future events or otherwise.

® : OxyContin, OxyNEO, OxyNorm, MST Continus, MS Contin, Tramundin, Tramcontin, Zytram, Targin, Norspan, Sovenor, BuTrans, Restiva, Lignopad, Transtec,  Flutiform, Uniphyl, Biphentin, Targin, Betadine, Betaplast, and Repithel are Registered Trademarks of Mundipharma in Singapore  and are Registered Trademarks or Trademarks of Mundipharma in other countries. Timoptic, Timoptic XE, Saflutan, Trusopt and Cosopt are Registered Trademarks of Mundipharma in Argentina and are Registered Trademarks or Trademarks of Mundipharma in Middle East, Africa, and Latin America.  Folotyn – is a Registered Trademark of Allos Therapeutics, Inc; Zevalin is a Registered Trademark of Bayer Schering Pharma AG; Lodotra is a Registered Trademark of Horizon Pharma AG; Medifoam is a Registered Trademark of Genewel; Senokot is a Registered Trademark of Reckitt & Colman (Overseas). The foregoing are used under license from the respective owners, are registered in Singapore, and are Registered Trademarks or Trademarks in other countries.

Medicines include medical devices.

®: ALOXI and AKYNZEO are Registered Trademarks in Singapore and Registered Trademarks or Trademarks in other countries, of Helsinn Healthcare SA, Switzerland used under license.

®: TRAMAL is a Registered Trademark in Singapore and Registered Trademarks or Trademarks in other countries, of Grunenthal GmbH used under license.

™: Depocyte, Intermezzo, Mundesine, IRCodon and Oxinorm are Trademarks of Mundipharma in Singapore and are Registered Trademarks or Trademarks in other countries.

Analgesia

Analgesia is by far our largest area of expertise. Over the past 60 years, Mundipharma has introduced a number of products that have transformed the way pain is treated, offering oral, transdermal and parenteral delivery of analgesia to suit patient needs.

 

The product range includes:

OxyContin®, OxyNEO®, OxyContin OTR® – tablets are a prolonged-release formulation containing oxycodone.

OxyNorm® – capsules, liquid, concentrate and injection area immediate-release formulations that contain the active ingredient oxycodone. OxyNorm® is available as IRcodon™ tablets in Korea and OxiNorm™ sachets in Japan.

Lignopad® plaster contains 5% lidocaine in a medicated plaster formulation.

Tramal®, Tramundin®, Tramcontin®, Zytram ® – tablets/capsules/injections have the active ingredient tramadol. Tramadol is available as TRAMCONTIN® sustained-release tablets (China and Columbia), TRAMUNDIN® tablets (Malaysia, Philippines and the Middle East) and ZYTRAM® tablets (Korea). Mundipharma is the distributor of TRAMAL® in the Philippines.

MST Continus® , MS Contin ® – film-coated tablets contain morphine sulfate.

Norspan® (Sovenor® in Malaysia and South Africa, BuTrans® in Middle East and North Africa and RESTIVA® in Brazil) is a transdermal patch that delivers a constant dose of buprenorphine during seven days of wear.

Targin® tablets – a prolonged-release oral combination of the opioid agonist oxycodone and the opioid antagonist naloxone, is a recent addition to the oxycodone range.

Transtec® – a transdermal patch containing buprenorphine.

Mundipharma actively works to ensure that its medicines are marketed responsibly and in accordance with the regulatory frameworks in each country it operates in. Mundipharma prides itself on being an ethical company, and continues to work closely with regulators, and within strict regulatory constraints, to address the unmet need of patients across the emerging world.

Background Image

Oncology

The existing range of oncology products includes treatments for neuro-oncological and haematological malignancies.

The product range includes:

Depocyte™ – a sustained-release liposomal formulation of cytarabine for intrathecal injection.

Folotyn® (pralatrexate injection) – a folate analog metabolic inhibitor.

Palonosetron (injection/oral) is a 5HT3 receptor antagonist.

Zevalin® – a CD20-directed radiolabeled antibody injection (to be administered after rituximab).

Netupitant / Palonosetron – an oral fixed combination of a 5HT3 receptor antagonist, palonosetron and an NK1 receptor antagonist, netupitant.

Mundesine™ – an oral form of transition-state analog inhibitor of purine nucleoside phosphorylase.

 

Background Image

Ophthalmology

Our ophthalmology portfolio consists of a range of products that cover the primary treatment methods for patients with open-angle glaucoma.

The product range includes:

TIMOPTIC®, TIMOPTIC XE® and TIMOPTIC® Preservative-Free
 – contain the active ingredient timolol, which is a beta-blocker, and is used as anti-glaucoma preparation

SAFLUTAN®
 – eye drops that contain the active ingredient tafluprost, which is a prostaglandin analogue, and is used as anti-glaucoma preparation

TRUSOPT® and TRUSOPT® Preservative-Free – eye drops that contain the active ingredient dorzolamide hydrochloride, which is a carbonic anhydrase inhibitor, and is used as anti-glaucoma preparation

COSOPT® and COSOPT® Preservative-Free
 – eye drops that contain the combination of active ingredient dorzolamide hydrochloride and timolol maleate, which combines a carbonic anhydrase inhibitor and a beta-blocker, and is used as anti-glaucoma preparation

 

Background Image

Respiratory

Mundipharma is committed to building a presence in respiratory disease, particularly asthma, which is a chronic and debilitating disease that affects approximately 300 million people worldwide.

 

The product range includes:

Flutiform® (fluticasone/formoterol) – a combination therapy in an aerosol delivery system (pressurized metered dose inhaler or pMDI) that brings together fluticasone propionate, an inhaled corticosteroid, with formoterol fumarate, a long-acting β2 agonist.

Uniphyl® is a controlled-release tablet containing anhydrous theophylline for oral administration.

 

Background Image

Specialty Care

Rheumatoid arthritis (RA) is a chronic and progressive auto-immune disease that causes swelling and damage to cartilage and bone around the joints, most commonly hands, feet and wrists. A common and debilitating symptom of RA is morning stiffness of the affected joints. RA is a painful condition and can have a negative impact on a person’s ability to perform tasks on a day-to-day basis.*

 

The product range includes:

LODOTRA® – a modified-release prednisone

Intermezzo – tablets containing a low dose of zolpidem for oral consumption

Biphentin® – a controlled release capsule containing methylphenidate hydrochloride.

Targin RLS® – a fixed combination of prolonged-release oxycodone/naloxone.

 

Consumer Health

The BETADINE® (Povidone Iodine) range of products is trusted in hospitals around the world for over 45 years to prevent and treat infections. It is an important first line of defence against topical infection.

 

The product range includes:

The BETADINE® Wound Care
Range of products can be used to treat minor cuts, wounds, grazes and burns, and are available in a variety of convenient formats making them suitable for use at home and outdoors.

BETADINE® Oral and Throat Care
Rapidly kills the three groups of organisms that cause throat infections – bacteria, viruses, and fungi, in as fast as 30 seconds. The active ingredient of BETADINE® Gargle and Mouth Wash, povidone iodine, is more effective compared to other antiseptics in oral and throat care+ remedies, in killing wider range of microbes. Use BETADINE® Gargle and Mouthwash to help prevent a minor sore throat from escalating into a major throat infection.

Clinical studies have demonstrated that BETADINE® Gargle and Mouth Wash is useful in lowering absentee rates due to common cold and influenza. It is effective in killing the viruses that cause avian flu, common flu, and common colds. Practicing proper oral and throat care with BETADINE® Gargle and Mouth Wash may also help limit the spread of airborne infections during an outbreak. It can also be used for treating mouth ulcers.

BETADINE® Feminine Care
Vaginal Pessaries and Vaginal Douche are effective medicated products for treating a wide range of vaginal infections. By killing germs such as bacteria, fungi, and protozoa which cause vaginal infection, BETADINE® pessaries and vaginal douche also help relieve vaginal infection symptoms such as vaginal discomfort, abnormal discharge, odour and itchiness.

BETADINE® pessaries and vaginal douche also help relieve vaginal infection symptoms such as vaginal discomfort, abnormal discharge, odour and itchiness.

Compared with other treatment options, BETADINE® medicated feminine care has lower relapse rates and allows quicker recovery of the friendly bacteria in the vagina.

Poor hygiene is among the factors that can cause an overgrowth of bacteria causing vaginal infection. Women at all ages are in need of a daily intimate feminine hygiene to keep their genital area clean and dry. The practice of proper feminine intimate hygiene has a positive effect in reducing vaginal pH and improvement of vaginal symptoms.Wash the feminine intimate area with *BETADINE® Feminine Wash.

BETAPLASTTM/Medifoam® – a moist wound dressing.

Senokot® – a natural vegetable laxative.

BETADINE® Repigel/Repithel® – a liposomal hydrogel with 3% povidone-iodine.

BETADINE® Feminine Wash is a cosmetic body wash.

 

↓